24 results
8-K
EX-99.1
CTKB
Cytek BioSciences Inc
9 Jan 24
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
6:05am
guidance during its earnings call expected to be held at the end of February 2024.
J.P. Morgan Healthcare Conference
Cytek is providing … these updates in advance of its participation in the 42nd Annual J.P. Morgan Healthcare Conference, which begins today in San Francisco, CA. CEO Wenbin Jiang
S-3ASR
EX-1.2
pdo rabfj94vy
26 Aug 22
Automatic shelf registration
5:07pm
DEF 14A
4adanq
14 Apr 22
Definitive proxy
4:01pm
10-K
b5rpzv1c
17 Mar 22
Annual report
4:38pm
10-Q
li4gcchhitpcz2y
3 Sep 21
Quarterly report
12:00am
424B4
9x3j4t 84
23 Jul 21
Prospectus supplement with pricing info
4:12pm
S-1/A
vgjoy
13 Jul 21
IPO registration (amended)
9:03pm
S-1
s3rd 66htbbv547i
2 Jul 21
IPO registration
4:34pm